KEYWORD

COVID-19

Phillip Felgner

UC Irvine receives initial $33 million in federal support for vaccine research

Philip Felgner to lead multi-institutional pandemic planning effort

Leigh Turner, UCI Professor of Public Health

UC Irvine study exposes risks of direct-to-consumer stem cell, exosome COVID-19 therapy ads

More than 75 percent of clinics operated by these businesses are in U.S. and Mexico

Woman smiling at the camera

Study highlights the impact of COVID-19 on U.S. infant food security, feeding practices

Denise Payán, UCI assistant professor of health, society & behavior, was a member of a team of psychology and public health experts who investigated the impact of COVID-19 on infant food security and feeding practices in the U.S. The study, recently published online in the journal Maternal & Child Nutrition, found that disruptions to formula […]

Dr. Steven Goldstein

UC Irvine, UCLA researchers identify new therapeutic approach to prevent ARDS

Designed peptide blocks top cause of life-threatening lung damage with pneumonia

Carbon dioxide pollution dropped on California freeways during pandemic

UCI researchers’ results could help cities curb future greenhouse gas emissions

Payam Heydari (left) and Philip Felgner

Two UCI researchers named fellows by the National Academy of Inventors

Philip Felgner and Payam Heydari recognized for innovations that benefit society

Andrew Noymer (left) and Chen Li.

An early warning system for future pandemics?

Researchers hunt for tipoffs in social media and public data

Cameron Wiley and doctoral candidate Kennedy Blevins (left) and Sarah Pressman (right).

UCI research team finds positivity is not equally protective against illness across races

Study supports consideration of cultural factors when developing health interventions

Alison Holman

UCI study examines distorted time perception during pandemic

May be an important risk factor to target with early interventions

John Chaput

UCI-developed COVID-19 test detects, identifies specific variants with 100% accuracy

RNA-based method advances personalized medicine for improved patient care